Novitium Pharma LLC

FDA Regulatory Profile

Summary

Total Recalls
6
510(k) Clearances
0
Inspections
5
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-0443-2024Class IIIDigoxin Tablets, USP 62.5 mcg (0.0625 mg), 100-count bottles, Rx Only, Manufactured by: Novitium PhaMarch 25, 2024
D-0389-2024Class IIIDigoxin Tablets, USP 125mcg, (0.125 mg), 1000-count bottle, Rx Only, Manufactured by: Novitium PharmMarch 4, 2024
D-0311-2020Class IINovitium Pharma Ranitidine Capsules 150 mg 500 capsules Rx Only Manufactured by: Novitium Pharma LLCOctober 25, 2019
D-0312-2020Class IINovitium Pharma Ranitidine Capsules 300 mg 30 capsules Rx Only Manufactured by: Novitium Pharma LLC October 25, 2019
D-0310-2020Class IINovitium Pharma Ranitidine Capsules 150 mg 60 capsules Rx Only Manufactured by: Novitium Pharma LLC October 25, 2019
D-0313-2020Class IINovitium Pharma Ranitidine Capsules 300 mg 100 capsules Rx Only Manufactured by: Novitium Pharma LLCOctober 25, 2019